Risks of CHD identified by different criteria of metabolic syndrome and related changes of adipocytokines in elderly postmenopausal women

Journal of Diabetes and its Complications

Volumn 21, Issue 5, 2007, Pages 315-319

  Ding, Qun Fang ^a,b   Hayashi, Toshio ^a   Zhang, Xin Jun ^b   Funami, Jan ^a   Ge, Ling ^b   Li, Jun ^c   Huang, Xiao Li ^b   Cao, Li ^b   Zhang, Jun ^b   Akihisa, Iguchi ^a  

^a Nagoya University   (Japan)

^b SICHUAN UNIVERSITY   (China)

^c NONE

Author keywords

Adipocytokines; Cardiovascular diseases; Metabolic syndrome

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; METABOLIC SYNDROME X; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL;

ADIPOKINES; ADIPONECTIN; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CORONARY DISEASE; CYTOKINES; HUMANS; INSULIN; LIPIDS; METABOLIC SYNDROME X; MIDDLE AGED; POSTMENOPAUSE; RISK FACTORS;

EID: 34548401786     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2006.03.005     Document Type: Article

References (21)

1. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Medicine 15 (1998) 539-553
2. Athyros V.G., Ganotakis E.S., Elisaf M., and Mikhailidis D.P. The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Current Medical Research and Opinion 21 8 (2005) 1157-1159
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Journal of the American Medical Association 285 (2001) 2486-2497
4. Expert Panel on Metabolic Syndrome of Chinese Diabetes Society. Recommendations on metabolic syndrome of Chinese Diabetes Society (Chinese). Chinese Journal of Diabetes 12 (2004) 156-161
5. Ford E.S. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 28 (2005) 2745-2749
6. Goldstein B.J., and Scalia R. Adiponectin: A novel adipokine linking adipocytes and vascular function. Journal of Clinical Endocrinology and Metabolism 89 6 (2004) 2563-2568
7. Gu D.F., Reynolds K., Wu X.G., Chen J., Duan X.F., Reynolds R., Whelton P.K., He J., and for the InterASIA Collaborative Group. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365 (2005) 1398-1405
8. Hunt K.L., Resendez R.G., Williams K., Haffner S.M., and Stern M.P. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 110 (2004) 1251-1257
9. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Available from (2005). http://www.idf.org/webdata/docs/Metabolicsyndrome-definition.pdf (Accessed 2 September)
10. Kannel W.B., and McGee D.L. Diabetes and cardiovascular disease: The Framingham study. Journal of the American Medical Association 241 (1979) 2035-2038
11. Lihn S.A., Pedersen S.B., and Richelsen B. Adiponectin: Action, regulation and association to insulin sensitivity. Obesity Reviews 6 (2005) 13-21
12. Matsuzawa Y. Metabolic syndrome-Definition and diagnostic criteria in Japan. Journal of the Japan Society of International Medicine 94 (2005) 188-203
13. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 7 (1985) 412-419
14. Misso M.L., Jang C., Adams J., Tran J., Murata Y., Bell R., Boon W.C., Simpson E.R., and Davis S.R. Differential expression of factors involved in fat metabolism with age and the menopause transition. Maturitas 51 (2005) 299-306
15. Nakamura Y., Shimada K., Fukada D., Shimada Y., Ehara S., Hirose M., Kataoka T., Kamimori K., Shimodozono S., Kobayashi Y., Yoshiyama M., Takeuchi K., and Yoshikawa J. Implications of plasma concentrations of adiponectin in patients with coronary artery diseases. Heart 90 (2004) 528-533
16. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., and Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. Journal of the American Medical Association 291 (2004) 1730-1737
17. Poehlman E.T., Toth M.J., and Gardner A.W. Changes in energy balance and body composition at menopause: A controlled longitudinal study. Annals of Internal Medicine 123 (1995) 673-675
18. Reynolds K., and He J. Epidemiology of the metabolic syndrome. American Journal of the Medical Sciences 330 6 (2005) 273-279
19. Tankó L.B., Bagger Y.Z., Qin G., Alexandersen P., Larsen P.J., and Christiansen C. Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Circulation 111 (2005) 1183-1890
20. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., and Tataranni P.A. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 86 5 (2001) 1930-1935
21. Wilson P.W.F., D'Agostino R.B., Parise H., Sullivan L., and Meigs J.B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112 (2005) 3066-3072